Insider Trading & Ownership of JOHN JOHNSON
-
Location
-
Seattle, WA
-
Summary
-
The estimated net worth of JOHN JOHNSON is at least $8,068,722 dollars as of 19 Dec 2025. JOHN JOHNSON is the Director of Xeris Biopharma Holdings, Inc. and owns shares of Xeris Biopharma Holdings, Inc. (XERS) stock worth about $5,037,227. JOHN JOHNSON is the Executive Chairman, Director of Applied Therapeutics, Inc. and owns shares of Applied Therapeutics, Inc. (APLT) stock worth about $2,915,000. JOHN JOHNSON is the Director of Verastem, Inc. and owns shares of Verastem, Inc. (VSTM) stock worth about $116,495.
-
Signature
-
/s/ Beth Hecht, Attorney-in-Fact
Notify me when JOHN JOHNSON files a new Insider Trading report.
⭐ Subscribe ⭐